Marwood Group Announces Strategic Investment from funds managed by Lee Equity Partners, LLC and Appointment of Chris Librizzi as CEO

Librizzi joins as Chief Executive Officer from EY-Parthenon to lead the firm's next phase of growth; Lee's investment will fuel innovation in existing offerings and expansion of capabilities

NEW YORK, Sept. 9, 2026 /PRNewswire/ -- Marwood Group, a leading healthcare-focused advisory and consulting firm, today announced a strategic investment from Lee Equity Partners. The partnership will support Marwood's continued growth, including acquisitions and senior team hires, to deepen and expand its capabilities.

Alongside the investment, Marwood has announced that Chris Librizzi, formerly of EY-Parthenon, has joined as Chief Executive Officer. Richard Jeanneret, a senior advisor to Lee Equity and long-time leader at EY also has joined Marwood as Executive Chairman.

Librizzi and Jeanneret will work closely with Walt Breakell (President), Lee Alvarez (Chief Revenue Officer), Martin Sobel (Chief Product Officer) and the rest of Marwood's current executive leadership team, all of whom are remaining with the company through this transaction. Breakell will continue to serve on Marwood's Board. Together, they'll focus on further building Marwood's strong, ongoing performance and bringing even greater value to its clients.

In recent years, Marwood has been expanding its business with an increasing focus on compliance, strategy, and performance improvement to complement its longstanding position as a market leader for executives and investors in healthcare policy and reimbursement matters.

Lee Equity provides Marwood with additional capital and a growth partner as the firm accelerates this strategy and provides its clients with market-leading capabilities across their most complex decisions and operational issues. Marwood intends to leverage its partnership with Lee Equity to deepen its ability to serve private equity firms across their transaction lifecycle, invest in its people and create career opportunities, and expand into growing client segments, including hospitals, payors and life sciences companies.

As part of this accelerated growth phase, Chris Librizzi has joined the firm as CEO. Librizzi comes to Marwood from EY-Parthenon, where he spent the past five years leading its US strategy consulting business. Before that, Librizzi built and led EY's corporate strategy function firmwide and served on the company's US Board and Executive Committee.

Librizzi brings highly relevant experience to Marwood. EY-Parthenon grew exponentially by diversifying into new customer segments and offerings, much as Marwood intends to do. Librizzi had a significant track record at EY-Parthenon of developing new products and client solutions, leading senior hires, and successful acquisition integrations.

"It is exciting to be joining Marwood, with its longstanding reputation for market leadership and unparalleled expertise, at a time when the company is clearly poised for growth. The policy and regulatory questions that Marwood is known for answering link to so many aspects of our clients' businesses and investment theses, and we are focused on building even more market-leading capabilities to enhance the value we provide," said Librizzi.

Jeanneret has also joined Librizzi and the Marwood team to help lead the firm into the future. With a 20-year track record at EY and one of its longest-serving board members, Jeanneret has served as strategic business advisor to numerous corporate boards, multinational organizations and private equity firms. At EY, he built multiple market-leading businesses and guided the execution of successful M&A transactions.

"We are excited to partner with Marwood after a long-standing relationship with its leadership team. Marwood's expertise and quality of advice is differentiated in the healthcare services community. With high-quality healthcare-specific knowledge as its foundation, the firm is well-positioned to grow organically and inorganically," added John Eppler, Principal at Lee.

"Marwood has long been a trusted advisor to clients in all-things healthcare, both operating and investing," stated Lee Alvarez, Marwood's Chief Revenue Officer. "We now have the fresh committed capital to drive an even greater focus on innovation in our core business, while extending the deep expertise we are known for into new growth areas. With the established momentum in the business, with Chris at the helm and with LEP as our partner, the Marwood leadership team is looking forward to this next chapter."

About Marwood Group
Marwood Group is a leading advisory and consulting firm serving healthcare, life sciences and private equity clients. Marwood provides deep policy, regulatory and reimbursement expertise alongside consulting and performance improvement services, helping clients navigate a complex and evolving healthcare landscape. For more information, visit www.marwoodgroup.com.

About Lee Equity Partners
Lee Equity Partners, LLC is a middle-market private equity firm that partners with businesses in the financial and healthcare services sectors. Over nearly two decades the firm has utilized its thematic based investment strategy and deep sector knowledge to identify and partner with talented management teams to accelerate growth and build market leading businesses. Additional information is available at www.leeequity.com.

SOURCE Smarts Agency